aesthetics

Face | Body | Intimacy Expand Your Practice

With the EMpire™

Skin & Muscle Fat & Muscle Incontinence Muscle Vaginal Rejuvenation Skin Cellulite
 The Areas From Head
You Will Treat to Toe

Face
Submentum Neck

Décolletage Bra Fat

Arms
Upper Arms

Lateral Abdomen

Abdomen
Love Handles Buttocks

Hands
Pelvic Floor
Saddle Bags Thighs

Calves
 Skin & Muscle
The first and only hands-free device that
simultaneously treats facial skin and Wrinkle Reduction
SKIN

muscles without needles in just 20 minutes.

on average

• Can treat forehead, eyebrows, cheeks, and

jawline simultaneously
MUSCLE
Muscle Tone
• Captures the needle-phobic patient population on average

• Hands-free and easy to delegate procedure

• Improves ROI and patient results when

MORE
combined with other facial procedures and LIFT
on average
membership programs

“EMFACE will do for the face what EMSCULPT did for the body.”

Yael Halaas, M.D.

*Data on file. Results and patient experience may vary.

 Fat & Muscle
EMSCULPT NEO is the only non-invasive SC
ULPT N

technology that simultaneously uses RF and

EM

EO
HIFEM+ to eliminate fat and build muscle. O
DY PA RT

S
B
This results in more fat reduction and more
muscle growth than any single gold standard Treated
Areas
procedure.
• Treats larger patient population with no BMI limitation.

• Contrary to other devices, there are no upfront click

-30
Fat
%

fees. on average*

• 2-for-1 procedure ensures high patient satisfaction:

more pronounced results for less time and money.

•M
 ore treatments in less time means more profit and less
+25
Muscle
%
“EMSCULPT NEO is operator independent, takes half the time, patients don’t have to go fi rst for fat treatment, and
then again for muscle treatments. It does everything in the 30-minute session, which makes it is more cost and time
operating expenses. on average*
effective. And the most important thing, patients don’t have to wait for months to feel a difference.”

Bruce Katz, M.D.

*Data on file. Results and patient experience may vary. The data shown represents the average results of 3 EMSCULPT NEO’s clinical studies1-3.
 Incontinence
A breakthrough HIFEM® energy based 75
treatment for all types of incontinence.
Pad
• Treats entire pelvic floor area. Reduction*

• 75% of the treated patients reduced or totally

eliminated the use of hygienic pads.*
RELAXED AND STIMULATED
LOOSENED PELVIC FLOOR
• Comfortable treatment without downtime yields PELVIC FLOOR BY EMSELLA
higher patient retention and conversion rates.
Patients Remain BLADDER BLADDER
Fully Clothed
• Operator and consumable free therapy maximizes PELVIC PELVIC
practice profitability. FLOOR FLOOR
MUSCLES MUSCLES

95 “We place all our stress incontinence and overactive bladder patients on this chair. They are loving the
28-minute treatments. It is so easy sitting fully clothed on the BTL Emsella, reading a magazine, and
getting a full pelvic workout without the sweat!”
Patient
Satisfaction* Red Alinsod, M.D.

*HIFEM Technology Can Improve Quality of Life of Incontinent Patients, Berenholz J., MD, Sims T., MD, Botros G., MD, Individual results may vary.
 Muscle
EMSCULPT is the world’s first non-invasive
procedure to build muscle and tone the
buttocks without needles and anesthesia. 2,500
Installed Units

• The leading muscle-building procedure with

scientifically backed results. M
Sc ien t

if i
HIF

c
• Awarded the most worth-it procedure by Realself.*

pu

s
bl

n
ic a t io
• Generates incremental revenue from patients
looking for more than simple fat reduction. Backed By
Science

• Non-Thermal, Non-Ionizing, Non-Radiating

treatment eases the safety concerns of patients.

96
“A decrease in the amount of fat and an increase in the amount of muscle is truly what you want,
you want to define. You don't want to just get rid of fat and have everything beneath it flabby.”
Average Patient
Satisfaction* Carolyn Jacob, M.D., FAAD

*Data on file. Results and patient experience may vary. Patients shown in the B&A pictures are within +/- 2,25 kg of their original weight unless specified.
 Cellulite
EMTONE is the first and only device that
simultaneously delivers both thermal and
mechanical energy to treat all 5 causes of Higher Increase
of Elastin*
cellulite.
• Treats all skin and body types without a limitation
of maximum dimples per session.

• Comfortable treatment without needles, incisions

or downtime, helps patient retention.
Higher Increase
of Collagen*
• Works perfectly as a standalone as well as an
adjunct treatment.

• Fast and comfortable procedure increases

conversion rates.
Faster Than
Standalone Therapies*
“Patients have responded enthusiastically to early treatment experience. This is a “no downtime”, FDA
cleared treatment for cellulite* and is a wonderful addition to our clinical algorithms.”
Brian M. Kinney, M.D., FACS

*The percentage indicates the level of difference of simultaneous application compared to consecutive application. Brian M Kinney, Dian Kanakov, Penka Yonkova.
Histological examination of skin tissue in the porcine animal model after simultaneous and consecutive application of monopolar radiofrequency and targeted pressure energy
 Vaginal Rejuvenation
BEFORE AFTER EMFEMME 360

The EMFEMME 360 is the shortest non-invasive

procedure for the treatment of vaginal laxity INCREASED BLOOD
and sexual dysfunction with 360° volumetric RF Procedure for Ease of Use CIRCULATION AND
INCREASED AMOUNT
and Patient Comfort
technology and unique Temperature Therapy OF COLLAGEN AND
ELASTIN
Tracker (3T).
• Shortest 8-minute RF intimate wellness procedure BEFORE AFTER EMFEMME 360

• Real-time temperature feedback and dynamic

impedance technology for reproducible results Shortest Treatment
AN ATROPHIC SAMPLE “ESTROGENIZED-LIKE”
on the Market OF PAP-SMEAR CELLS SAMPLE OF PAP-SMEAR CELLS
• Procedure with easy and comfortable treatment (VAGINAL HEALTH INDEX: 7) (VAGINAL HEALTH INDEX: 19)
PRE-TREATMENT* POST-TREATMENT*
technique

• Can be combined easily with EMSELLA to improve

overall feminine health and wellness
93 “Other energies such as lasers work but are more invasive and have a greater chance of causing burns or
scarring in that sensitive and intimate area. EMFEMME 360 RF is naturally non-invasive, and the feedback-based
mechanisms that govern treatment make it easy to delegate to staff.”
Satisfied Patients
on Average* Kimberly L. Evans, M.D., FACOG

*Data on file. Results and patient experience may vary.

 Skin
The world’s only technology that 19
simultaneously delivers RF and Ultrasound for
the treatment of more than 20 body areas. Increase in Skin
Density
• Customizable with unmatched versatility offering
solutions for various indications.

• Non-invasive treatment for everyone without any BMI

or skin type restrictions.

• Repeated treatments encourage deeper patient Increase

in Collagen
loyalty and increase opportunities to expose your
patient base to new treatment options.

• Minimal consumable costs make treatments more

affordable and increase practice profitability.
“What I found with the Exilis Ultra is there is no limitation. The only limitation is our imagination. So I can
treat any part of the body on either sex.”
Recognition Rate for
Different Body Areas Suneel Chilukuri, M.D.

19% inCrease in Skin Density – MCDANIEL, David, et al. Two-treatment protocol for skin laxity using 90-Watt dynamic monopolar radiofrequency device with real-time impedance intelligence monitoring. Journal of drugs in dermatology:
JDD, 2014, 13.9: 1112-1117.; 2.9x Increase in Collagen – Fritz K. et Al., Dermatologic Therapy 2015;28(3):122-5; 92% Recognition Rate for Different Body Areas – Chilukuri S, Denjean D, Fouque L.; Treating multiple body parts for skin laxity and fat
deposits using a novel focused radiofrequency device with an ultrasound component: Safety and efficacy study. J Cosmet Dermatol. 2017;00:1–4. https://doi.org/10.1111/jocd.12448
As Seen On Dozens of Peer
Reviewed Studies
Novel Approach to Facial Rejuvenation by Treating
Skin and Muscle Tissue for Wrinkles Reduction:
SYNCHRONIZED RF &Preliminary
HIFEM: Data from Multicenter Clinical Trial
MULTICENTER ABDOMINAL IN VIVO MUSCLE HISTOLOGY STUDY
MRI STUDY Yael Halaas, M.D.1, Richard Gentile M.D.2
1. Plastic and cosmetic surgeon at Facial Plastic and Reconstructive Surgery, New York, NY, USA,

HISTOLOGICAL IN VIVO STUDY:
MAGNETIC RESONANCE IMAGING EVALUATION OF CHANGES IN GLUTEAL
THE MECHANISM MUSCLES AFTER TREATMENTS
EFFICACY AND SAFETY OF SIMULTANEOUS APPLICATION OF HIFEM AND NON-INVASIVE INDUCTION OF MUSCLE FIBER HYPERTROPHY AND ULTRASONOGRAPHY
2. Gentile Facial Plastic and Aesthetic Laser Center, Youngstown, OH, United States
MRI QUANTIFICATION OF
SYNCHRONIZED RADIOFREQUENCY FOR ABDOMINAL FAT REDUCTION Accepted for American Academy of Facial Plastic and Reconstructive Surgery 2022 Annual Meeting, Washington, DC
HYPERPLASIA: EFFECTS OF HIGH-INTENSITY FOCUSED ELECTROMAGNETIC STUDY: SUBCUTANEOUS FAT
HIFEM® EFFECTS ON BUTTOCKS
AND MUSCLE TONING: MULTICENTER MAGNETIC RESONANCE IMAGING (HIFEM) FIELD EVALUATED IN AN IN-VIVO PORCINE MODEL.
EVALUATION STUDY REDUCTION
Diane I. Duncan M.D.1, Prof. Dr. Ivan Dinev2
Carolyn Jacob MD1, David Kent MD2, Omer Ibrahim MD1
1. Plastic Surgery Associates, Fort Collins CO, USA CHANGES IN SUBCUTANEOUS ABDOMINAL FAT THICKNESS
WITH THE HIGH-INTENSITY FOCUSED
1. Chicago Cosmetic Surgery and Dermatology, Chicago, IL, USA; 2. Skin Care Physicians of Georgia, Macon, GA, USA FOLLOWING HIGH-INTENSITY FOCUSED ELECTRO-MAGNETICMRI AND
(HIFEM®) CT EVALUATION STUDY:

95.0% +25.3% -36.8%

2. General and Clinical Pathology, Faculty of Veterinary Medicine, Trakia University, Stara Zagora, Bulgaria
ELECTROMAGNETIC PROCEDURE FIELD TREATMENTS: A MULTI CENTER ULTRASOUND STUDY. 1-YEAR FOLLOW-UP
OF ACTION Published in Dermatologic Surgery journal, May 2021, DOI: 10.1097/DSS.0000000000003086 Presented at the Annual Meeting of the American Society for Laser Medicine and Surgery, 2018 Dallas, TX

INDUCTION OF FAT APOPTOSIS BY A NON-THERMAL DEVICE:
SAFETY AND MECHANISM OF ACTION OF NON-INVASIVE HIFEM®
Melanie Palm, M.D., MBA1 Bruce Katz M.D.1, Robert Bard M.D.2, Richard Goldfarb M.D.3,
1. Art of Skin Maryland, Solana Beach, CA, USA
Aaron Shiloh M.D.4, Dilyana Kenolova M.D.5 LONG-TERM FOLLOW-UP ON PATIENTS WITH HIFEM-INDUCED
HIGHLIGHTS ABDOMINAL TISSUE CHANGES: MRI AND CT ASSISTED QUANTIFICATION

Patient Skin Evenness Wrinkle

1. Juva Skin and Laser Center, Manhattan NY, USA; 2 Bard Cancer Diagnostics, Manhattan, NY, USA; 3. Center
TECHNOLOGY EVALUATED IN A HISTOLOGICAL PORCINE MODEL.
Published in Dermatologic Surgery journal, September 2020, DOI: 10.1097/DSS.0000000000002764 OF MUSCLE GROWTH AND FAT REDUCTION.
for SmartLipo & Plastic Surgery, Langhorne PA, USA; 4. Shiloh Vein and Aesthetic Institute, Philadelphia PA,

Satisfaction Improvement Reduction HIGHLIGHTS

USA; 5. Dermasense Dermatology Clinic, Burgas, Bulgaria.
Robert Weiss M.D.1, MVDr. Jan Bernardy2 Brian Kinney M.D. , David E Kent M.D.
1 2

1. Maryland Laser Skin, & Vein Institute, Hunt Valley, MD; 2. Veterinary Research Institute, Brno, CZ • Study included 41 subjects (22-62 y/o, BMI 21.2-34.3 kg/m2). Published in Dermatologic Surgery journal December 2019, Volume 45. 1. Clinical Associate Professor of Plastic Surgery, USC School of Medicine, Beverly Hills CA, USA
2. Skin Care Physicians of Georgia, Macon GA, USA
Presented at the Annual Meeting of the American Society for Laser Medicine and Surgery, 2018 Dallas, TX.

• MRI assessment showed 30.8% reduction in subcutaneous fat • In treated animals, the muscle mass in examined slices increased
HIGHLIGHTS
and 26.1% increase in muscle thickness at 3 months. by 23.44% (18934.0±5089.5 µm2) on average.
HIGHLIGHTS • 7 female subjects received four 30-minute HIFEM treatments on the buttocks.
HIGHLIGHTS HIGHLIGHTS
• 92 % increase in average apoptotic levels in fat cells from 18.75 %of gluteal muscles were reconstructed from MRI scans. • 21 subjects were recalled 1 year after 4-8 abdominal treatments for
• 3D volumes
at baseline to 35.95 % 8 hours post 1 treatment (levels in the
• Abdominal separation decreased by 19.8% at 6 months. • The average area per single muscle fiber increased by 16.4%
• 33 patients received four 30-minute treatments and werelong-term evaluation.
control subject remained stable). • Simultaneous enhancement (P<0.001) of all three gluteal muscles was found at 1-month (469.48 ±371.95 µm). evaluated 1 month post application.

Methodology
• The patients showed an average fat reduction of 14.63% 1 year
(+10.81%,
• The results show link between fat cells apoptosis and 197.98 cm ) and 3-month (+13.23%, 241.45cm ) follow-ups.
elevated
3 3
post-treatment.
levels of free fatty acids released during supramaximal muscle • Waist circumference was reduced by 6.7 cm at 6 months. • Ultrasonography calculated fat thickness in multiple measurement
contractions induced by the treatment. • The appearance of buttocks was improved with a visible lifting effect.
• The average number of muscle fibers increased by 7%, and
points covering the whole abdomen. • In comparison to baseline, the muscle thickness was increased
by 19.05%, and abdominal separation was reduced by 10.46%
• Theafter
• Blood analysis confirmed a rapid metabolic reaction
the treatment as supporting evidence of changes in the
thickness of gluteal adipose tissue was not affected.
• 24 subjects (23 females, 1 male) although not statistically significant, it indicates muscle
• fiber
On average 19.0 % (4.4 mm) reduction of fat was observed.1 year post-treatment.

subcutaneous fat tissue. No safety risks were identified. hyperplasia. The most significant reduction in fat (26.6 %) was observed
• Treatment results were preserved on average 1 year after the last
• Four 20-minute full face treatments in the subumbilical area.
session.

• Evaluation of High of
• Control animal did not show any significant changes in• any consistency
the with 0 non-responders; 21 out of 33 patients had
BASELINE 3 MONTHS AFTER greater than 15 % fat reduction.
• Wrinkle severity via automated 3D measured parameters. BASELINE 6-WEEK FU 1-YEAR FU

• 91 % satisfaction with treatment results.

photo assessment
• Patient satisfaction
• Treatment comfort

Don’t Take Our Word For It...

Microscopic analysis of the fat tissue confirmed that the amount of apoptotic cells increased
significantly after the treatments (right) compared to the baseline (left).

On the left: 3D reconstruction of the muscle volumes; musculus gluteus maximus (green), medius (yellow) and minimus (red).
On the right: standardized patient photography that shows a change in the buttock contour at 1 month (B, blue-dotted line) and 3 months
(C, green-dotted line) relative to the baseline (A).

MRI scans of a 62-year old female showing 14.6% muscle thickening, 29.2% reduction in abdominal
Sixty-two year old patient
Ultrasound measurements revelated that fat was reduced significantly (p<0.05) in all abdominal
separation, 45.6% fat reduction and 5.8 cm reduction in waist circumference.
areas, with the highest change seen in epi- and sub-umbilical regions.

Histological evaluation showed strong muscle fiber hypertrophy and indicated fiber hyperplasia.

Baseline 3M FU

MOST
WORTH IT
2020 PATIENTS’ CHOICE
EMSCULPT

Efficacy and safety have been tested in many multicenter studies using
... And Many More the most reputable scientific methods such as MRI, CT, US and Histology.

More Than 70 Offices
Around the Globe
Growing to meet your needs
1993 Continuous growth worldwide
BTL: Over 30 Years
Of Innovation
2,800+ Employees More Than 400 2 Focused Divisions:
Worldwide Engineers Medical and Aesthetics
The content of this document is intended for informational purposes only. Not all products and indications are licenced in your country, for more information contact
your local representative. Results and patient experience may vary. EMFACE® should only be operated by physician or healthcare professional. Client should be
continuously monitored and procedure discontinued immediately if the client reports pain or excessive heat. Do not apply the procedure over hair or scar tissue, or
if the client has electronic or metal implants. Side effects may include temporary damage to natural skin (crust, blister, and burn). The Therapy Discomfort Button
should always be accessible to the client. Results and experience may vary. In the EU, EMFACE® is intended for aesthetic procedures such as facial rejuvenation and
contouring by wrinkles reduction and skin laxity improvement by means of toning and lifting of muscles and skin. EMSCULPT NEO® should only be operated by
physician or healthcare professional. Patient should be continuously monitored and therapy discontinued immediately if the patient reports pain or excessive heat.
Do not apply therapy over clothing or scar tissue, or if patient has electronic or metal implants. As with any heat-based therapy, burns may result. The Therapy
Discomfort Button should always be accessible to the patient. Patient results and patient experience may vary. In the EU, EMSCULPT NEO® is intended for the
treatment of obesity by fat reduction through neuromuscular stimulation, radiofrequency-induced lipolysis and increase of blood flow, EMSELLA Chair Applicator
is intended to provide pelvic floor muscle strengthening for treatment of urinary incontinence in male and female patients. EMSCULPT® is intended solely for
professional use in healthcare facilities. Stop therapy immediately if patient reports uncomfortable pain at the site of application during therapy. Do not apply
therapy if patient has electronic or metal implants. Patient results and experience may vary. In the EU, EMSCULPT® is intended for the treatment of obesity by fat
reduction through neuromuscular stimulation and increase of blood flow, EMSELLA Chair Applicator is intended to provide pelvic floor muscle strengthening
for treatment of urinary incontinence in male and female patients. EMSELLA® should only be operated by physician or healthcare professional. Stop therapy
immediately if patient reports uncomfortable pain at the site of application during therapy. Do not apply therapy if patient has electronic or metal implants. Patient
results and experience may vary. In the EU, BTL EMSELLA® is intended to provide pelvic floor muscle strengthening for treatment of urinary incontinence in male
and female patients. EMTONE® shall be used by medically educated healthcare professional. Patient should be continuously monitored to avoid possible burns.
Do not apply therapy over hair or if patient has electronic or metal implants. Patient results and experience may vary. EMTONE® is a radio-frequency combined
with targeted pressure energy device for treatment of obesity and localized obesity by fat reduction, skin laxity treatment, skin regeneration, treatment of gynoid
lipodystrophy, alleviation of pain and alleviation of muscle spasms.In the EU, EMFEMME 360 with BTL-785F is intended for the treatment of sexual dysfunction
after vaginal delivery by means of improvement of vaginal laxity. Results and patient experience may vary. Patients shown in the B&A pictures are within +/- 2.25 kg
of their original weight unless specified. As with any medical procedure, ask your doctor if the EXILIS ULTRA 360 procedure is right for you. The BTL EXILIS ULTRA
360™ in the EU, intended for obesity treatment by means of controlled reduction of fat cells, induced by a radiofrequency field in cooperation with ultrasound, and
the treatment of sexual dysfunction after vaginal delivery by means of improvement of vaginal laxity. BTL®, EXILITE®, EXILIS®, VANQUISH®, UNISON®, CELLUTONE®,
CORE TO FLOOR®, EMSCULPT®, EMSCULPT NEO®, EMSELLA®, EMFEMME 360®, EMBODY®, EMTONE® and HIFEM® are registered trademarks in the United States
of America, the European Union, or other countries. The products, the methods of manufacture or the use may be subject to one or more U.S. or foreign patents or
pending applications, see www.btlnet.com/patents. Trademarks EMSCULPT, EMSCULPT NEO, EMSELLA, EMTONE, EMFEMME 360, and EMBODY are associated
with the EM™ family of products and services.*Data on file. Results and patient experience may vary. As with any medical procedure, ask your doctor if the procedure
is right for you. ©2022 BTL Group of Companies. All rights reserved. BTL® and EMFACE ® are registered trademarks in the United States of America, the European
Union, or other countries. The products, the methods of manufacture, or the use may be subject to one or more U.S. or foreign patents or pending applications,
see www.btlnet.com/patents. Trademarks EMSCULPT, EMSCULPT NEO, EMSELLA, EMTONE, EMFEMME 360, EMFACE, and EMBODY are associated with the
EM™ family of products and services. 1Abdominal toning and the reduction of subcutaneous fat with the combination of a novel radiofrequency treatment and the
HIFEM procedure - MRI scan study. Jacob C. et al. Presented at ASDS 2020 Virtual Meeting. 2Radiofrequency heating and HIFEM delivered simultaneously - the BTLAESTHETICS.COM
first sham-controlled randomized trial. Katz B. et al. Presented at ASDS 2020 Virtual Meeting. 3Ultrasound evaluation of the simultaneous RF and HIFEM treatments
on human fat tissue. Denkova R. Source: U.S. Food and Drug Administration. 510(k) Premarket Notification: K192224.Published online on 5 December, 2019.
 770-77AECTB2PFEN104
BTL-Aesthetics_CAT_Bbb2-product-family_EN104